IL-18 代谢重编程表达 CAR 的自然杀伤 T 细胞并增强其抗肿瘤活性 IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity. PubMed 2026/01/10 发表Mol TherQ1 · IF 11.4(JCR 2025) 靶点:CD19靶点:GD2靶点:GPC3技术:NK 细胞技术:NKT 细胞肝细胞癌神经母细胞瘤白血病
靶向肿瘤血管以改善经体外 T 细胞衔接双特异性抗体武装的 T 细胞的抗肿瘤活性 Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. PubMed 2023/03/01 发表J Immunother CancerQ1 · IF 11.7(JCR 2025) 靶点:GD2靶点:HER2靶点:GPC3技术:双特异性抗体神经母细胞瘤骨肉瘤